International Biotechnology (LON:IBT) Stock Crosses Below 200-Day Moving Average – Should You Sell?

Shares of International Biotechnology (LON:IBT) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 680.90 ($8.57) and traded as low as GBX 674 ($8.48). International Biotechnology shares last traded at GBX 680 ($8.56), with a volume of 39,054 shares changing hands.

International Biotechnology Price Performance

The business’s 50-day moving average is GBX 694.15 and its two-hundred day moving average is GBX 680.90. The company has a quick ratio of 0.32, a current ratio of 0.46 and a debt-to-equity ratio of 9.66. The company has a market capitalization of £251.33 million, a P/E ratio of 1,416.67 and a beta of 0.21.

International Biotechnology Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, January 24th. Shareholders of record on Thursday, December 19th will be paid a GBX 15.56 ($0.20) dividend. This represents a yield of 2.21%. The ex-dividend date is Thursday, December 19th. This is an increase from International Biotechnology’s previous dividend of $14.50. International Biotechnology’s dividend payout ratio is 6,041.67%.

Insider Transactions at International Biotechnology

In other news, insider Katherine Cornish-Bowden acquired 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The shares were acquired at an average price of GBX 713 ($8.97) per share, for a total transaction of £10,695 ($13,457.91). Company insiders own 4.18% of the company’s stock.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.